04/15/2024
8:52 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
4:29 PM | Vistagen Therapeutics (Filer)
| Form PRE 14A | |
03/06/2024
5:00 PM | SAXE JON S (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Cunningham Ann Michelle (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | Curley Joanne (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | FitzPatrick Margaret M (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:00 PM | GIN JERRY B (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/06/2024
5:00 PM | Rotunno Mary L. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
11:15 PM | Vistagen Therapeutics (Filer)
| Form EFFECT | |
02/14/2024
5:18 PM | CITADEL ADVISORS LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:56 AM | Point72 Asset Management, L.P. (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024
5:27 PM | StemPoint Capital LP (Filed by)
Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/03/2024
4:17 PM | Singh Shawn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | Adler Reid G. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:09 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
3:44 PM | Vistagen Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
8:46 PM | Vistagen Therapeutics (Filer)
| Form 8-K/A | |
11/06/2023
3:27 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
7:14 PM | Prince Joshua S. (Reporting)
Vistagen Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
3:34 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/16/2023
3:37 PM | TCG Crossover GP II, LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/16/2023
3:01 PM | CITADEL ADVISORS LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/12/2023
3:04 PM | GREAT POINT PARTNERS LLC (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/06/2023
3:05 PM | COMMODORE CAPITAL LP (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
10/06/2023
3:05 PM | COMMODORE CAPITAL LP (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
3:47 PM | Point72 Asset Management, L.P. (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/02/2023
6:15 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
3:26 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
7:43 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
4:27 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2023
12:08 PM | Anderson Cynthia Lynn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/23/2023
12:09 PM | Anderson Cynthia Lynn (Reporting)
Vistagen Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
7:40 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
7:00 AM | Vistagen Therapeutics (Filer)
| Form 424B5 | |
08/07/2023
7:35 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2023
3:54 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
07/28/2023
3:55 PM | Vistagen Therapeutics (Filer)
| Form DEFA14A | |
07/18/2023
5:02 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
3:35 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2023
3:35 PM | BlackRock Inc. (Filed by)
Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
06/28/2023
4:11 PM | Vistagen Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
The "Smart Money" Is Ready for May 1st Are You? (Ad) Former Wall Street VP: "Buy This Stock Now"
Five of America's Most Successful Investors Bought Shares in The Same Company.  One Former Wall St. Trader Explains Why… |
06/28/2023
3:28 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
7:35 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:43 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
4:30 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
3:33 PM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
8:26 AM | Vistagen Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
